phthalocyanine has been researched along with pyrimidinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, K; Evensen, JF; Moan, J; Peng, Q; Rimington, C; Western, A | 1 |
| Ben-Hur, E; Malik, Z; Mendelson, E; Salzberg, S; Smetana, Z; Wagner, P | 1 |
| Chen, H; Lim, WQ; Tham, HP; Thng, TGS; Venkatraman, SS; Xu, C; Xu, K; Zhao, Y; Zheng, M | 1 |
3 other study(ies) available for phthalocyanine and pyrimidinones
| Article | Year |
|---|---|
Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer.
Topics: Animals; Female; Hematoporphyrins; Indoles; Isoindoles; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Photochemotherapy; Photolysis; Pyrimidinones; Radiation-Sensitizing Agents; Spectrometry, Fluorescence | 1987 |
Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines.
Topics: Animals; Chlorocebus aethiops; Gene Products, env; Indoles; Isoindoles; Kinetics; Light; Photosensitizing Agents; Pyrimidinones; Simplexvirus; Vero Cells; Viral Proteins | 1998 |
Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Combined Modality Therapy; Drug Delivery Systems; Female; Heterografts; Humans; Imidazoles; Indoles; Isoindoles; Melanoma; Mice, Nude; Nanostructures; Needles; Oxidative Stress; Oximes; Photochemotherapy; Photosensitizing Agents; Pyridones; Pyrimidinones; Silicon Dioxide; Skin Neoplasms | 2018 |